Contact Us: 1.201.849.4431

The Healing Power of Botanical Therapeutics®

 
12-04-2014

Herborium Exceeds Target Sales for Black Friday and Cyber Monday by 80% Over 2013

Fort Lee, N.J. December 4th, 2014  Herborium® Group, Inc. (OTC Pink: HBRM),  www.Herborium.com, a Botanical Therapeutics® Company and the provider of unique all  botanical medicines (Botanical Therapeutics®)  announced today that its Black Friday and Cyber Monday sales results grew 80% over the same sales events in 2013.

Two 24 hours sales events known as Black Friday and Cyber Monday drew unprecedented sales from USA, Canada and Europe and not only exceeded 2013 sales  target but also maintain  the company  healthy margin since the promotion  for those two events (2 days) did not exceeded 15%.

The recent sales results continue surpassing Herborium’s  2013 performance in every area and confirm the highest expectations about 2014 yearly results.

Reported three quarters sales for 2014 was already 31% higher than the entire sales for 2013 , and 2014 3rd Quarter gross profit margin increased 80% over the same period of 2013.

 “The Company growth in the USA and abroad continues. We will be announcing new sales initiatives still commencing in 2014.  We look forward to the very successful end of 2014 and the future growth and profitability of our novel   all natural medicines-Botanical Therapeutics®”. Commented Dr. Agnes P. Olszewski, CEO and Chairwoman of Herborium Group.

 

About Herborium Group, Inc.

Herborium Group, Inc., a botanical therapeutics® company that develops, license and markets proprietary, botanical based medicinal products to consumers and healthcare professionals. The Company business model focuses on emerging market opportunities spearheaded by the growth of a new market sector located between high-cost, high-risk, ethical pharmaceuticals and commoditized classic nutraceuticals (supplements).  The Company uses clinical validation and a proactive regulatory strategy based on the FDA Guidance for Industry: Botanical Drug Products (FDA Guidance 2004) to establish and maintain a differential advantage.  Herborium has secured a pipeline of botanical ingredients based products in the areas of dermatological needs, wellness and energy, prostate health, women’s health and selected sexual disorders resulting from cardiovascular disease, use of anti-depressants, diabetes, surgical procedures, and other problems. Herborium Group sells its products in the United States, the United Kingdom, and continental Europe through a network of distributors, specialty retailers, and e-commerce. For more information, please visit www.herborium.com, and www.acnease.com.

Safe Harbor Statement:  This release contains forward-looking statements with respect to the results of operations and business of Herborium Group, Inc., which involves risks and uncertainties.  The Company's actual future results could materially differ from those discussed.   The Company intends that such statements about the Company's future expectations, including future revenues and earnings, and all other forward looking statements be subject to the "Safe Harbors" provision of the Private Securities Litigation Reform Act of 1995.

Contact Information: Herborium Group, Inc.
Email: InvestorsRelations@Herborium.com


Information provided on Herborium.com about medical conditions, symptoms, and related products is not intended to be a substitute for professional medical advice. Visitors to this site should not use this information to diagnose or treat a health problem, symptom, concern or disease without consulting with their individual qualified healthcare provider. Statements contained on this website have not been evaluated by the FDA. Herborium products are not intended to diagnose, heal, cure or prevent disease.